Key Takeaways
- Board members at Conagra acquired a total of 42,500 shares on April 14, investing approximately $609,000 as the stock traded close to its 52-week bottom.
- Year-to-date performance shows CAG declining 17% amid volume challenges, shrinking margins, and reduced fiscal projections.
- Third-quarter results disappointed with earnings per share of $0.39 (versus $0.40 expectations) and a 1.9% revenue decline compared to last year.
- Morgan Stanley reduced its price objective from $17 to $15 this Thursday while maintaining an “equal weight” stance.
- Wall Street consensus reflects a “Reduce” recommendation with a mean price target of $15.80 — comprising 1 Buy, 13 Hold, and 4 Sell ratings.
Two board members at Conagra recently demonstrated confidence in the company by making substantial share purchases. Richard H. Lenny, a director, acquired 25,000 shares at $14.34 per unit on April 14, totaling an investment of $358,500. Fellow director John J. Mulligan followed suit the same day, purchasing 17,500 shares at $14.31 each for a total of $250,425.
This collective investment of approximately $609,000 occurred while shares traded near their yearly floor of $14.04. The acquisition significantly increased Mulligan’s stake by 542%. Following this transaction, Lenny’s holdings now total 229,340 units with an estimated market value of $3.3 million.
The context surrounding these purchases is noteworthy. CAG’s recent decline accelerated on April 9 after BNP Paribas downgraded shares from Outperform to Neutral and reduced its price objective from $19 to $16. The stock dropped below $16 during that trading session.
Challenges continued to mount. On April 13, Conagra announced John Brase as its incoming CEO and president. Jefferies noted that Brase would inherit “high leverage, ongoing inflationary pressures, and margin compression.”
Third Quarter Results Disappoint
Earlier this month, Conagra released its fiscal third-quarter financial results, which fell short of market projections. The packaged foods company reported earnings of $0.39 per share, one cent below the Street’s $0.40 forecast. Sales reached $2.79 billion, narrowly surpassing the anticipated $2.76 billion.
Despite the marginal revenue beat, the underlying trends painted a concerning picture. Sales declined 1.9% on a year-over-year basis, while earnings per share dropped significantly from $0.51 in the comparable period last year. Management also lowered its full-year guidance, citing challenging macroeconomic conditions and sustained inflationary headwinds.
Shares have tumbled 17% since the start of 2026, while the S&P 500 has advanced 4.2% during the same timeframe.
Wall Street Maintains Cautious Outlook
Analyst sentiment remains muted following recent performance. Morgan Stanley lowered its price target on CAG to $15 from $17 on Thursday while maintaining an “equal weight” rating. This revised target suggests merely 3.6% upside potential from Wednesday’s closing price.
Morgan Stanley’s move followed similar actions by other firms. JPMorgan reduced its target from $19 to $17 in March. Both TD Cowen and Deutsche Bank lowered their objectives to $14. Stifel trimmed its forecast to $15 this week.
According to MarketBeat’s current consensus, analysts rate CAG as “Reduce” with 1 Buy, 13 Hold, and 4 Sell recommendations. The average price target stands at $15.80.
CAG shares opened Thursday trading at $14.49. The stock’s 50-day moving average rests at $16.75, while the 200-day moving average sits at $17.38 — both considerably above current trading levels.
A notable metric: CAG currently offers a dividend yield approaching 9%, representing the highest yield among S&P 500 constituents. The average dividend yield for income-paying stocks in the benchmark index is 2.3%.
Institutional ownership accounts for 83.75% of outstanding shares. Multiple smaller investment firms have modestly increased their positions during recent reporting periods, though these additions have been relatively minor.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
